Comparison of Nasal CPAP and Nasal SIMV in Transient Tachypnea of Newborn

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01499238

Enrollment

Registered

2011-12-26

Start date

2011-12-31

Completion date

2012-03-31

Last updated

2011-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transient Tachypnea of Newborn

Keywords

Efficacy, safety, nasal SIMV, nasal CPAP, infants who are >35 gestational week with wet lung

Brief summary

The investigators aimed to compare the efficacy of nasal SIMV and nasal CPAP in patients with wet lung.

Detailed description

We aimed to compare two types of ventilatory support in cases of transient tachypnea of newborn who are \>35 gestational week.

Interventions

DEVICENasal SIMV

rate: 30-50/min, PIP: 16-20, PEEP: 4-6, FİO2: 40%

DEVICEnasal CPAP

PEEP: 4-6 mmHg, FİO2: 40%

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

2 Hours to 3 Days

Healthy volunteers

Inclusion criteria

* \>35 gestational week * wetlung

Exclusion criteria

* major congenital anomalies

Design outcomes

Primary

Measure	Time frame
efficacy of nasal SIMV and nasal CPAP in infants with wet lung who are >35 weeks gestational age	3 months

Secondary

Measure	Time frame	Description
Complications of respiratory support, respiratory insufficiency	3 months	pneumothorax

Countries

Turkey (Türkiye)

Contacts

Primary ContactGamze Demirel, MD

kgamze@hotmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026